Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
New research shows that people can be genetically predisposed to having sleep problems like insomnia and that these signs can show up in early childhood.
The National Zoo's three giant pandas, Mei Xiang, Tian Tian and their cub Xiao Qi Ji. on Wednesday began their long trip to China, leaving behind an empty panda exhibit with no certainty that pandas ever would again take up residence there.
The CDC released a report with troubling statistics about the number of reported syphilis cases in newborns, with cases rising 10-fold in the last decade and nearly 32% in just one year.
